thyroid cancer cell lines ftc-133 Search Results


human follicular thyroid carcinoma cell line ftc133  (ScienCell)
90
ScienCell human follicular thyroid carcinoma cell line ftc133
XIST knockdown inhibits the cell and tumor growth of thyroid cancer ( a ) XIST expression in five thyroid cancer cell lines <t>(FTC133,</t> BCPAP, TPC-1, SW1736 and KAT18) and a normal human thyroid epithelium cell line (TEC) was examined using real-time PCR assays. b XIST knockdown was achieved by transfection of si-XIST#1 or si-XIST#2, as confirmed using real-time PCR assays. c - d The cell viability was determined using MTT assays. e - f The DNA synthesis ability was determined using BrdU assays. g - i The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected KAT18 cells were examined. j - l The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected TPC-1 cells were examined. The data are presented as mean ± SD of three independent experiments. * P < 0.05, ** P < 0.01
Human Follicular Thyroid Carcinoma Cell Line Ftc133, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thyroid+cancer+cell+lines+ftc-133/human+follicular+thyroid+carcinoma+cell+line+ftc133/pmc06249781-58-7-40
Average 90 stars, based on 1 article reviews
human follicular thyroid carcinoma cell line ftc133 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ftc 133 follicular thyroid carcinoma cell line  (FUJIFILM)
90
FUJIFILM ftc 133 follicular thyroid carcinoma cell line
XIST knockdown inhibits the cell and tumor growth of thyroid cancer ( a ) XIST expression in five thyroid cancer cell lines <t>(FTC133,</t> BCPAP, TPC-1, SW1736 and KAT18) and a normal human thyroid epithelium cell line (TEC) was examined using real-time PCR assays. b XIST knockdown was achieved by transfection of si-XIST#1 or si-XIST#2, as confirmed using real-time PCR assays. c - d The cell viability was determined using MTT assays. e - f The DNA synthesis ability was determined using BrdU assays. g - i The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected KAT18 cells were examined. j - l The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected TPC-1 cells were examined. The data are presented as mean ± SD of three independent experiments. * P < 0.05, ** P < 0.01
Ftc 133 Follicular Thyroid Carcinoma Cell Line, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thyroid+cancer+cell+lines+ftc-133/ftc+133+follicular+thyroid+carcinoma+cell+line/pm31062662-57-26-39
Average 90 stars, based on 1 article reviews
ftc 133 follicular thyroid carcinoma cell line - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


XIST knockdown inhibits the cell and tumor growth of thyroid cancer ( a ) XIST expression in five thyroid cancer cell lines (FTC133, BCPAP, TPC-1, SW1736 and KAT18) and a normal human thyroid epithelium cell line (TEC) was examined using real-time PCR assays. b XIST knockdown was achieved by transfection of si-XIST#1 or si-XIST#2, as confirmed using real-time PCR assays. c - d The cell viability was determined using MTT assays. e - f The DNA synthesis ability was determined using BrdU assays. g - i The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected KAT18 cells were examined. j - l The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected TPC-1 cells were examined. The data are presented as mean ± SD of three independent experiments. * P < 0.05, ** P < 0.01

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling

doi: 10.1186/s13046-018-0950-9

Figure Lengend Snippet: XIST knockdown inhibits the cell and tumor growth of thyroid cancer ( a ) XIST expression in five thyroid cancer cell lines (FTC133, BCPAP, TPC-1, SW1736 and KAT18) and a normal human thyroid epithelium cell line (TEC) was examined using real-time PCR assays. b XIST knockdown was achieved by transfection of si-XIST#1 or si-XIST#2, as confirmed using real-time PCR assays. c - d The cell viability was determined using MTT assays. e - f The DNA synthesis ability was determined using BrdU assays. g - i The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected KAT18 cells were examined. j - l The tumor volume and tumor weight derived from si-XIST#1 or si-XIST#2-transfected TPC-1 cells were examined. The data are presented as mean ± SD of three independent experiments. * P < 0.05, ** P < 0.01

Article Snippet: A human follicular thyroid carcinoma cell line, FTC133 derived from a lymph node metastasis of a follicular thyroid carcinoma, a human thyroid cancer papillary cell line, BCPAP, and a normal human thyroid epithelium cell line (TEC) were purchased from the ScienCell Research Laboratories (Carlsbad, CA, USA).

Techniques: Knockdown, Expressing, Real-time Polymerase Chain Reaction, Transfection, DNA Synthesis, Derivative Assay

XIST targets miR-34a to negatively interact with miR-34a ( a ) KAT18 and FTC133 cells were transfected with miR-34a mimics or miR-34a inhibitor to achieve miR-34a expression, as confirmed using real-time PCR assays. b XIST expression was determined using real-time PCR assays. c miR-34a expression in response to XIST knockdown was determined using real-time PCR assays. d - e Luciferase reporter gene assays were performed to confirm the direct targeting of XIST to miR-34a. f Association of miR-34a and XIST with AGO2 in HEK293 cells. Detection of AGO2 and IgG using Immunoblotting assays. g RIP assay in HEK293 cells transfected with control miRNA (miR-NC) or miR-34a followed by real-time PCR to detect XIST associated with AGO2. The data are presented as mean ± SD of three independent experiments. ** P < 0.01

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling

doi: 10.1186/s13046-018-0950-9

Figure Lengend Snippet: XIST targets miR-34a to negatively interact with miR-34a ( a ) KAT18 and FTC133 cells were transfected with miR-34a mimics or miR-34a inhibitor to achieve miR-34a expression, as confirmed using real-time PCR assays. b XIST expression was determined using real-time PCR assays. c miR-34a expression in response to XIST knockdown was determined using real-time PCR assays. d - e Luciferase reporter gene assays were performed to confirm the direct targeting of XIST to miR-34a. f Association of miR-34a and XIST with AGO2 in HEK293 cells. Detection of AGO2 and IgG using Immunoblotting assays. g RIP assay in HEK293 cells transfected with control miRNA (miR-NC) or miR-34a followed by real-time PCR to detect XIST associated with AGO2. The data are presented as mean ± SD of three independent experiments. ** P < 0.01

Article Snippet: A human follicular thyroid carcinoma cell line, FTC133 derived from a lymph node metastasis of a follicular thyroid carcinoma, a human thyroid cancer papillary cell line, BCPAP, and a normal human thyroid epithelium cell line (TEC) were purchased from the ScienCell Research Laboratories (Carlsbad, CA, USA).

Techniques: Transfection, Expressing, Real-time Polymerase Chain Reaction, Knockdown, Luciferase, Western Blot, Control